All News

Merck will present late-breaker abstracts at upcoming IAS 2017 conference.

Cancer diagnoses delayed by an average of 9 days in patients with preexisting conditions.

A microneedle patch allows the flu vaccine to be safely and effectively self-administered.

Over-the-counter therapy could improve overall wellbeing in patients with multiple sclerosis.

The Biologics License Application for ibalizumab is under review for the treatment of multidrug resistant HIV-1.

More than 80% of patients with chronic urticaria report quality of life issues.

Findings confirm no or negligible placental transfer of anti-TNF drug in women with rheumatoid arthritis.

New York Senate passes bill to charge drug dealers with homicide for opioid-related deaths.

Messaging based on patient medical records allow for more personalized care in HIV and other conditions.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

Eradicating hepatitis C virus with antiviral drugs found to improve comorbid conditions.

A recently-published study has found another reason to enjoy a cup of coffee.

When I talk to people about their careers—especially when they are about to transition into a new one—sometimes people have a similar “what did I just do?” feeling.

July is National Ultraviolet (UV) Awareness Month and the role of the pharmacist in sun safety is crucial.

We need outside innovation to fix our broken system.

Pharmacists can play an important role in preconception counseling.

Antibiotic resistance is making gonorrhea increasingly harder to treat, the World Health Organization (WHO) warned in a recently published report.

The CDC has released trends on influenza activity in the United States during the 2016-2017 flu season. This data is updated yearly to consider new strains of the virus circulating in society and the overall length of the season.

Customers may end up paying more for prescription drugs when they use certain pharmacy discount cards.

Diabetes' propensity to cause metabolic derangement is directly responsible for a looming epidemic of diabetic kidney disease (DKD). And left unchecked, DKD can progress to end-stage kidney disease (ESKD).

How can we reduce the burden of type 1 diabetes? Automated insulin delivery systems could be the answer.

The ability of manufacturers to convey the efficacy and safety of a new biosimilar is crucial.

A diabetes wearable device can measure cortisol, glucose, and interleukin-6 in sweat to track disease progession.

Dutasteride (Avodart) increases blood sugar, A1C, and blood lipids.

The trial is the first to compare Xeljanz alone or in combination with MTX versus adalimumab plus MTX.

Boehringer Ingelheim seeks to launch its biosimilar to Humira.

VNS Therapy system is an implanted device that prevents seizures in patients with drug-resistant epilepsy.

DigniCap Cooling System approved for use among patients with solid tumors treated with certain types of chemotherapy.

Reports confirm 10 hepatitis A-related deaths in Detroit area over the past year.